Notably, CD47p/AZE–paclitaxome-2 performed markedly better than CP–PTX and PGG–PTX nanoparticles on circulation time, extravasation, intratumoral diffusion, the ability to avoid MPS clearance and therapeutic effect by achieving significant greater tumor suppression and metastasis remission. Here, CP is linked to neoplasm.